December 5, 2023 11:15 AM EST
News Briefing

Ab­b­Vie’s new AI deal; Roche's PhI­II win in breast can­cer; Spring­Works to raise $275M

Kyle LaHucik

Senior Reporter

Ayisha Sharma

News Reporter

Plus, news about Eli­go Bio­science, Eye­Point, Xenon and Merus:

Ab­b­Vie signs AI pact: For $30 mil­lion up­front, the phar­ma is

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

FDA picks con­tro­ver­sial doc­tor Vinay Prasad as CBER di­rec­tor, in about-face from Marks

Biotech stocks plunge and in­dus­try fig­ures left to won­der af­ter Prasad's FDA ap­point­ment

What Vinay Prasad means for CBER, vac­cines, drug ap­provals and more

No­vo Nordisk trims growth fore­cast as GLP-1 com­pounder ban yet to go live

Even as ques­tions grow over RFK Jr.'s vac­cine pol­i­cy, BioN­Tech does­n't see ‘near-term’ im­pact

sponsored

In one of the riski­est in­dus­tries — Biotech — a sure­fire way to neu­tral­ize some of that risk emerges

A service from the Financial Times